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assumed that the "headaches" were nitrate-induced and proceeded
to encourage patients to persevere through the initial phases of
therapy. Furthermore, the side effects requiring crossover or ter-
mination were not judged to be "hypersensitivity" to nitrates
because a documented history of nitrate intolerance was clearly an
exclusion criterion of the study. We therefore felt that these sub-
jects should be included for analysis.
Those patients who were titrated to maximal therapy may well
represent a limitation of protocol design, and this probably should
have been emphasized more clearly as one limitation of this type
of study. We believed, however, that we employed dosage sched-
ules that are commonly used in the community at large and that
comparative data at these levels would be useful. A future inves-
tigation might well address the comparison of a calcium channel
blocker with long-acting nitrates in an open label fashion where
the dosage of nitrates can be confidently advanced to "the limits
of tolerance" without fear of jeopardizing patient comfort or safety.
Finally, in response to the question of costs of respective drug
therapies, there is little or no argument that use of any of the
calcium channel blocking agents is more costly than conventional
therapy with long-acting nitrates. This fact, however, has not
dampened any of the enthusiasm for these agents nor has it pre-
cluded their widespread use. Perhaps not cost, but cost-effective-
ness, should also be addressed in future clinical trials.
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Closed Chest Catheter Ablation of an
Accessory Pathway in a Patient
With Permanent Junctional
Reciprocating Tachycardia
Gang et al. (I) describe successful catheter ablation of the acces-
sory pathway in the permanent form of junctional reciprocating
tachycardia. We disagree that theirs is "the first report of suc-
cessful application of the procedure in this rhythm disorder,"
because a similar report has been published (2). In addition, we
believe that some concepts concerning the initiating mechanisms
of this arrhythmia, as reported in the article, should be modified.
Our previous report (3), which is quoted by Gang et aI., dem-
onstrates that several mechanisms other than critical acceleration
of the atrial rate can be responsible for the tachycardia initiation.
Thus, we observed initiation of permanent junctional reciprocating
tachycardia without any apparent antecedent event or after an atrial
or ventricular premature contraction, as well as after a junctional
escape beat.
VITTORIO MONDA, MD
MARINO SCHERILLO, MD
GIUSEPPE CRITELLI, MD, FACC
1stituto di I Clinica Medica
II Policlinico, via S. Pansinis
80131, Naples, Italy
References
I. Gang ES, Oseran D, Rosenthal M, et al. Closed chest ablation of an accessory
pathway in a patient with permanent junctional reciprocating tachycardia. J Am
Coli Cardiol 1985;6:1167-71.
2. Critelli G, Monda Y, Perticone F, Coltorti F, Scherillo M, Condorelli M. Closed
chest ablation of accessory pathways. Experimental model and successful appli-
cation in a patient with incessant supraventricular tachycardia. G Ital Cardiol
1984;14:181-7.
3. Critelli G, Gallagher 11, Monda Y, Coltorti F, Scherillo M. Rossi L. Anatomic
and electrophysiologic substrate of the permanent form of junctional reciprocating
tachycardia. J Am Coli Cardiol 1984;4:601-10.
Reply
At the time of submission of our manuscript, we were not aware
of a previous English language report of a successful catheter
ablation of an accessory pathway in a patient with the' 'permanent"
form of AV reciprocating tachycardia. Clearly, such a report had
already been published in the Italian cardiologic literature. For this
oversight, we offer our apology.
We certainly accept the comments of Monda et al. regarding
mechanisms of initiation of tachycardia in patients with permanent
junctional reciprocating tachycardia. Our introductory comments
reviewed the common mode of initiation of the tachycardia (ac-
celeration of the atrial rate prior to onset of the tachycardia), which
constitutes a sufficient but by no means necessary condition for
the onset of the tachycardia. This was invariably the way in which
the tachycardia was initiated in our patient. Our comments do not
exclude other modes of tachycardia initiation. Regardless of the
way the tachycardia is described, we are gratified that both patients
appear to have been cured of their troublesome tachycardias. In
our case, the follow-up period has now extended to 17 months
without a single recurrence of the tachycardia.
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